Patel NG, Kesselheim AS, Darrow JJ - Journal of Health Politics, Policy and Law
Political interference in the FDA’s Emergency Use Authorization (EUA) process can undermine the agency’s scientific independence and public trust in FDA approval decisions. Expanding advisory committee involvement, increasing transparency around agency decision‑making, and better managing internal agency disagreement are all strategies the FDA should consider to improve the EUA process.
VIEW SOURCE
Daval CJR, Kesselheim AS - STAT
Mulsant SS, Kesselheim AS, Naci H - Journal of Cancer Policy
Avorn J - MedPage Today